Target Group Inc (CBDY)
0.0058
0.00 (0.00%)
USD |
OTCM |
Apr 26, 10:15
Target Group Total Liabilities (Quarterly): 15.81M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.81M |
| September 30, 2023 | 15.18M |
| June 30, 2023 | 15.59M |
| March 31, 2023 | 15.00M |
| December 31, 2022 | 14.13M |
| September 30, 2022 | 13.39M |
| June 30, 2022 | 13.88M |
| March 31, 2022 | 15.97M |
| December 31, 2021 | 15.22M |
| September 30, 2021 | 15.05M |
| June 30, 2021 | 17.82M |
| March 31, 2021 | 19.16M |
| December 31, 2020 | 16.56M |
| September 30, 2020 | 15.52M |
| June 30, 2020 | 10.61M |
| March 31, 2020 | 9.303M |
| December 31, 2019 | 12.68M |
| September 30, 2019 | 6.521M |
| June 30, 2019 | 6.926M |
| March 31, 2019 | 8.851M |
| Date | Value |
|---|---|
| December 31, 2018 | 3.437M |
| September 30, 2018 | 3.735M |
| June 30, 2018 | 2.203M |
| March 31, 2018 | 1.665M |
| December 31, 2017 | 2.062M |
| September 30, 2017 | 1.896M |
| June 30, 2017 | 1.921M |
| March 31, 2017 | 2.481M |
| December 31, 2016 | 2.114M |
| September 30, 2016 | 1.744M |
| June 30, 2016 | 1.278M |
| March 31, 2016 | 1.110M |
| December 31, 2015 | 1.089M |
| September 30, 2015 | 0.7125M |
| June 30, 2015 | 0.5052M |
| March 31, 2015 | 0.3904M |
| December 31, 2014 | 0.2796M |
| September 30, 2014 | 0.1162M |
| June 30, 2014 | 0.0011M |
| March 31, 2014 | 0.0011M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.521M
Minimum
Sep 2019
19.16M
Maximum
Mar 2021
13.91M
Average
15.05M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.841M |
| Shareholders Equity (Quarterly) | -6.973M |
| Debt to Equity Ratio | -0.0001 |
| Current Ratio | 0.2121 |